';
The Centers for Disease Control and Prevention (CDC) is partnering with pharmacies to offer on-site COVID-19 vaccination services for long-term care facilities when a vaccine becomes available. The Pharmacy Partnership for Long-term Care Program provides end-to-end management of the COVID-19 vaccination process, including cold chain management, on-site vaccinations, and fulfillment of reporting requirements, to facilitate safe vaccination of this patient population while reducing the burden on facilities and jurisdictional health departments.
The program is available for residents and staff in long-term care settings where most individuals are over 65 years of age, including skilled nursing facilities, nursing homes, assisted living facilities, residential care homes, and adult family homes. Additionally, facilities must be enrolled in the National Healthcare Safety Network (NHSN) to participate in the Pharmacy Partnership for Long-term Care Program; all facilities enrolled in the NHSN are eligible to participate. Intermediate Care Facility and intellectual disability (ICF/ID) facilities wishing to enroll in the NHSN should follow the enrollment steps listed here. Other facilities wishing to participate should visit here to see if they are eligible to enroll in the NHSN.
Participation in this program identifies your facility as willing to receive vaccines from CVS or Walgreens when the vaccine becomes available and if your facility is eligible to receive COVID-19 vaccine. The program is free of charge to facilities. CVS or Walgreens will bill private and public insurance for the vaccine administration fee. Additional information regarding COVID-19 vaccination costs can be found here.
All Long-term Care Facilities wishing to participate in the program must be registered with the Pharmacy Partnership to determine eligibility.
ODP providers of adult day programs/Community Participation Supports, residential services, and Intermediate Care Facilities willing to receive the vaccine through this Partnership program may complete this online form. Please respond by 11:59 pm EDT on Friday, November 6, 2020
If you have any questions please email.
Previously, the Office of Developmental Programs (ODP) released ODPANN 20-106 on October 30, 2020. The date for acceptance of public comments was incorrect. We regret the error. Please note that the public comment period is 30 days. Comments will be accepted until 11:59 pm on Monday, November 30, 2020. ODP has re-issued a corrected Announcement 20-106.
Your input matters! The Department of Human Services (DHS) and other stakeholders are working on suggestions to improve Pennsylvania’s Medical Assistance Transportation Program (MATP). Whether you use the program now or are eligible to use the program to get to your medical appointments, we welcome your feedback.
We invite you to attend one of the following three online sessions. You will hear more about the suggestions and have the chance to ask questions and give us your thoughts.
There are two ways to attend a session. You will receive more information closer to the date.
If you have questions about these sessions, please submit them here. Thank you for considering this opportunity to provide your opinion. We look forward to hearing from you.
On October 27, 2020, the Office of Long-Term Living (OLTL) notified all providers that interim reporting of COVID-19 related costs under Act 24 would be due on November 6, 2020. Because of unforeseen delays in web portal user provisioning for OLTL providers and recognition that this delay may not allow enough time for providers to gather and report their data, OLTL has changed its reporting requirements. There will be no interim report required of non-nursing facility providers. In preparation for final reporting on the use of Act 24 funding, now due December 21, 2020, OLTL recommends that providers begin to populate the applicable Excel reporting template now.
OLTL will offer a webinar to give non-nursing facility providers a chance to ask questions about reporting COVID-19 related costs under Act 24. Information about the webinar, including date and time, will be issued in the near future.
As a reminder, providers are advised to review the guidance for eligible COVID-19 costs in DHS’s Frequently Asked Questions and on the following US Department of Treasury websites: Coronavirus-Relief-Fund-Guidance and Coronavirus-Relief-Fund-Frequently-Asked-Questions. These documents outline the conditions and acceptable uses of Cares Act and Act 24 funding. Most importantly, the deadline by which costs must be incurred to be eligible under Act 24 is November 30, 2020.
Any provider who does not expect to use all or part of the Act 24 funding may return the funds to OLTL at:
PA Department of Human Services
Office of Long-Term Living
PO Box 8025
Harrisburg, PA 17105-8025
Please send any remaining questions about OLTL Act 24 reporting here.
The Department of Health and Human Services (HHS) recently released updated Provider Relief Fund Frequently Asked Questions (FAQs) for phase 3 of the general distribution of provider funds. The document includes updated questions and answers. It also includes information on corrections of data entered by recipients after application submission, use of funds for salaries and employment compensation, reporting the calculation of lost revenues attributable to COVID-19, and defining the term “health care related expenses.”